Shailesh Maingi Email & Phone Number

Chapel Hill, Nc, Us

Raleigh, North Carolina, Us

Kineticos Ventures Invests in biotechs looking to disrupt how drugs are developed, diseases are diagnosed and patients are treated. We focus on the areas of greatest medical need: Oncology, Neurosciences and Rare Diseases. We believe that disruptive technologies such as Cell and Gene Therapy, Gene Editing, mRNA/RNAi will dramatically change how medicine is practiced.

Raleigh, North Carolina, Us

Morrisville, North Carolina, Us

Inceptor Bio is developing multiple next-generation cell therapy platforms, including CAR-T, CAR-M and CAR-NK, to cure difficult-to-treat cancers with a focus on novel mechanisms to enhance immune cell performance in the tumor microenvironment.

Morrisville, North Carolina, Us

Gainesville, Florida, Us

Kincell Bio is a technology-forward contract development and manufacturing organization (CDMO) that streamlines analytical development, process development, CMC consulting and early-stage GMP cell therapy manufacturing. Our focus is on developing and manufacturing immune cell therapies, including autologous and allogeneic CAR-T, CAR-NK, and CAR-M programs. For more information, please visit our website at www.kincellbio.com.

Driving innovation in antibacterial drug discovery, our AMR NewCo, created by Kineticos through its AMR Accelerator Fund (KAMRA), is developing a new class of broad spectrum antibacterials to treat drug resistant infections. Building upon decades of groundbreaking research from one of the world’s leading Universities, our team has developed a novel class of antibiotics with the unique potential to treat even the most challenging drug-resistant infections. Our mission is clear: safeguard the future of modern medicine through the development of a robust pipeline of innovative antibiotics to treat patients with hospital- and community-acquired infections."

Morrisville, North Carolina, Us

Morrisville, North Carolina, Us

Chapel Hill, North Carolina, Us

Teach MBA895 - Strategic Value Creation for Life Sciences Companies for MBA program at UNC. Also, I've been an advisor to Kenan-Flagler's Launching the Venture, STAR program and MBA students.

Watertown, Ma, Us

Acquired by Recipharm in April 2022. Founded in 2019, Arranta Bio is a contract development and manufacturing organization (CDMO) specifically established to focus on serving companies seeking to develop and commercialize therapies targeting the human microbiome. Headed by a management team and technical experts with a proven track record in both process development and contract manufacturing through fermentation to lyophilization and encapsulation of live biopharmaceuticals, it offers the knowledge and resources necessary to help clients to develop and manufacture promising new microbiome therapies to meet the needs of patients. Additional information about Arranta is available at www.arrantabio.com.

St. Louis, Mo, Us

Acquired by Patheon in October 2014. Gallus Biopharmaceuticals is a clinical and commercial scale biologics contract manufacturer supporting global biopharmaceutical, pharmaceutical and emerging biotechnology companies. Gallus was purchased in 2011 by Ridgemont Equity Partners from the Centocor Biologics division of Johnson and Johnson.

Bs, Chemistry

Mba, Business